1. Home
  2. NUCL vs CDXS Comparison

NUCL vs CDXS Comparison

Compare NUCL & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NUCL

Eagle Nuclear Energy Corp. Common stock

N/A

Current Price

$7.87

Market Cap

308.2M

ML Signal

N/A

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$2.66

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUCL
CDXS
Founded
2023
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Major Chemicals
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
308.2M
256.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
NUCL
CDXS
Price
$7.87
$2.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
463.7K
863.4K
Earning Date
05-22-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.82
EPS
N/A
N/A
Revenue
N/A
$138,590,000.00
Revenue This Year
N/A
$7.73
Revenue Next Year
N/A
$14.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$4.63
$0.96
52 Week High
$14.22
$3.87

Technical Indicators

Market Signals
Indicator
NUCL
CDXS
Relative Strength Index (RSI) 34.45 59.00
Support Level $4.63 $2.41
Resistance Level $12.23 $2.73
Average True Range (ATR) 0.93 0.16
MACD -0.18 0.02
Stochastic Oscillator 1.36 97.12

Price Performance

Historical Comparison
NUCL
CDXS

About NUCL Eagle Nuclear Energy Corp. Common stock

Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds the rights to the mineable, measured and indicated uranium deposit in the United States, referred to as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated 37.73 million pounds of near-surface uranium and the adjacent Cordex Zone Eagle's SMR technology. Eagle's mission is to supply uranium to the growing nuclear energy industry and play a role in the global transition to clean, reliable, and affordable energy.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: